Chemomab Therapeutics Ltd. American Depositary Share CMMB

$1.90 -1.04% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K 6-K 2026-07-08 View →
6-K 6-K 2026-06-02 View →
4 Insider transaction 2026-06-01 View →
6-K 6-K 2026-05-14 View →
6-K 6-K 2026-05-06 View →
6-K 6-K 2026-04-28 View →
20-F 20-F 2026-03-23 View →
6-K 6-K 2026-03-20 View →
6-K 6-K 2026-03-19 View →
6-K 6-K 2025-11-21 View →
6-K 6-K 2025-08-22 View →
6-K 6-K 2025-08-14 View →
6-K 6-K 2025-07-25 View →
424B5 424B5 2025-07-25 View →
6-K 6-K 2025-07-01 View →
6-K 6-K 2025-05-27 View →
6-K 6-K 2025-05-15 View →
6-K 6-K 2025-04-15 View →
20-F 20-F 2025-04-04 View →
6-K 6-K 2025-03-27 View →
6-K 6-K 2025-03-20 View →
6-K 6-K 2025-03-03 View →
6-K 6-K 2025-02-19 View →
SC 13G SCHEDULE 13G 2024-11-21 View →
6-K 6-K 2024-11-18 View →
424B5 424B5 2024-11-15 View →
6-K 6-K 2024-11-14 View →
6-K 6-K 2024-10-11 View →
6-K 6-K 2024-08-21 View →
SC 13G SC 13G 2024-08-20 View →
6-K 6-K 2024-07-25 View →
6-K 6-K 2024-06-12 View →
6-K 6-K 2024-05-09 View →
6-K 6-K 2024-05-08 View →
6-K 6-K 2024-05-03 View →
20-F 20-F 2024-03-28 View →
6-K 6-K 2024-03-07 View →
6-K 6-K 2024-01-03 View →
6-K 6-K 2023-11-09 View →
6-K 6-K 2023-08-14 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.90
Market Cap
$14.07 million
52-Week Range
$1.35 – $4.92
Average Volume
224K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.